 |
| |
 | | Consultation for Management | |
- Ensure specialized obstetric care for diabetic women who are pregnant or planning pregnancies.
- Consider consultation with an endocrinologist and other professionals to ensure ideal glucose levels before and during pregnancy in diabetic women.
- Obtain specialty consultation for help in managing complications of diabetes in pregnant women or before conception.
|
| 
Ensure specialized obstetric care for diabetic women who are pregnant or planning pregnancies.  |
- Refer all women with pregestational diabetes to an obstetrician, or a high-risk obstetrician if available, as soon as pregnancy is diagnosed.
- Consider referral to a high-risk obstetrician for:
- Fetal and maternal risk determination as part of pregnancy planning
- Ongoing management if pre-conception fasting whole-blood glucose levels of 70 to 100 mg/dL and 2-hour postprandial levels of <140 mg/dL cannot be achieved before conception
| Background | Back to top
| 
Consider consultation with an endocrinologist and other professionals to ensure ideal glucose levels before and during pregnancy in diabetic women.  |
- Consider referral to an endocrinologist if the diabetic woman cannot achieve ideal glucose levels during pregnancy or before conception.
- Refer all women with diabetes during pregnancy, or women with diabetes considering pregnancy, to a:
- Nutritionist for instruction on the American Diabetes Association diet
- Certified diabetic educator for instruction in self-management of diabetes
| Background | Back to top
| 
Obtain specialty consultation for help in managing complications of diabetes in pregnant women or before conception.  |
- Obtain consultation with a:
- Nephrologist if proteinuria is detected in a pregnant patient
- Ophthalmologist for management of diabetic retinopathy
- Cardiologist in pregnant patients with coronary artery disease
- Neurologist in women with neuropathy or autonomic dysfunction
| Background | Back to top
|  | | FAQs |
|
| Elisha L. Brownfield, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|